Universal Health Services Inc header image

Universal Health Services Inc

UHS

Equity

ISIN US9139031002 / Valor 982101

New York Stock Exchange, Inc (2024-11-19)
USD 196.79-0.58%

Universal Health Services Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Universal Health Services, Inc. (UHS) stands as a prominent entity in the healthcare sector, offering a broad spectrum of hospital and healthcare services across the United States, Puerto Rico, and the United Kingdom. With a workforce of approximately 96,700 employees, UHS is committed to enhancing patient care and revolutionizing healthcare delivery. The company's operations encompass 27 Acute Care hospitals and 333 Behavioral Health inpatient facilities, alongside 27 freestanding emergency departments, and 21 outpatient facilities and ambulatory care centers spread over 39 states and Washington, D.C. In addition to its healthcare facilities, UHS extends its services through health insurance plans via Prominence Health and manages a physician network through Independence Physician Management. The company has also shown a commitment to supporting military personnel and their families through its Patriot Support Programs initiative. Furthermore, UHS is actively engaging in technological advancements in healthcare, as evidenced by its expansion of the Oracle Health electronic health record system across its network and its venture into digital health through partnerships and product development, including a Generative AI-powered staffing marketplace aimed at enhancing healthcare staffing solutions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.08.2024):

Net Income

Universal Health Services, Inc. reported a net income attributable to UHS of $261.8 million, or $3.82 per diluted share, during the first quarter of 2024. This is a significant increase compared to the net income of $163.1 million, or $2.28 per diluted share, reported in the first quarter of 2023.

Revenue Growth

Net revenues for Universal Health Services, Inc. increased by 10.8% to $3.844 billion during the first quarter of 2024, compared to $3.468 billion in the first quarter of 2023. This growth reflects the company's strong performance in its core operations.

Adjusted Net Income

On an adjusted basis, Universal Health Services, Inc.'s net income attributable to UHS was $253.1 million, or $3.70 per diluted share, in the first quarter of 2024. This compares to an adjusted net income of $167.6 million, or $2.34 per diluted share, in the first quarter of 2023.

EBITDA

Universal Health Services, Inc. reported earnings before interest, taxes, depreciation, and amortization (EBITDA net of NCI) of $525.9 million during the first quarter of 2024. This is an increase from $407.3 million in the first quarter of 2023. Adjusted EBITDA net of NCI was $525.8 million in the first quarter of 2024, compared to $421.1 million in the same period of 2023.

Cash Flow and Liquidity

During the first quarter of 2024, Universal Health Services, Inc. generated $396 million in net cash from operating activities, up from $291 million in the first quarter of 2023. As of March 31, 2024, the company had $733 million of aggregate available borrowing capacity under its $1.2 billion revolving credit facility.

Summarized from source with an LLMView Source

Key figures

44.7%1Y
58.7%3Y
38.8%5Y

Performance

25.5%1Y
31.5%3Y
39.8%5Y

Volatility

Market cap

11554 M

Market cap (USD)

Daily traded volume (Shares)

251,451

Daily traded volume (Shares)

1 day high/low

198.16 / 194.01

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Savaria Corp
Savaria Corp Savaria Corp Valor: 1385257
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.26%CAD 22.55
STERIS PLC
STERIS PLC STERIS PLC Valor: 47027903
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.34%USD 212.00
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1111046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.65%USD 25.55
Abbott Laboratories
Abbott Laboratories Abbott Laboratories Valor: 903037
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.20%USD 117.13
Galderma Group Ltd
Galderma Group Ltd Galderma Group Ltd Valor: 133539272
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.89%CHF 85.94
Novartis Inc
Novartis Inc Novartis Inc Valor: 567514
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.22%USD 103.27
GSK PLC
GSK PLC GSK PLC Valor: 120042705
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.68%USD 33.46
Almirall SA
Almirall SA Almirall SA Valor: 3180354
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.43%EUR 8.28
Pharma Mar SA
Pharma Mar SA Pharma Mar SA Valor: 56130572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.50%EUR 74.55
Faes Farma SA
Faes Farma SA Faes Farma SA Valor: 2837976
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.29%EUR 3.48